Qld's junior biotechs get a buffer against commercial realities
13 June, 2002 by Pete YoungQueensland is moving to ease the nasty shock felt by fledgling biotechs hatched in the tertiary sector's "sheltered workshop" environment when they encounter the cost of commercial office and lab space.
Aust researchers' IP rights at risk in NIH grab
13 June, 2002 by Melissa TrudingerAustralian scientists with funding from the US National Institutes of Health (NIH) are in danger of losing their rights to intellectual property resulting from their research.
Inquiry panel set up for fraud allegations
12 June, 2002 by Tanya HollisAn external inquiry will be held to investigate complaints made against University of NSW immunologist and renal specialist Prof Bruce Hall.
Vig govt chips in to Canadian synchrotron project
12 June, 2002 by Tanya HollisVictoria's government has committed $2 million to a collaboration with Canada aimed at developing synchrotron beamlines.
Qld dismisses deficit fears, promises continued biotech support
12 June, 2002 by Pete YoungA spokesman for Queensland Premier Peter Beattie yesterday dismissed fears that a $486 million operating deficit in accrued accounts this financial year will affect funds promised for biotech projects.
Vic govt open for business in San Francisco
11 June, 2002 by Tanya HollisEfforts to pursue North American business opportunities for Victorian biotechs have been redoubled with the opening today of a dedicated office in San Francisco.
Biocomm capital fund launched
11 June, 2002 by Tanya HollisVictorian biosciences commercialisation group Biocomm has launched an $11.5 million capital pool to help take the state's research to the market.
WEHI's Caples nets top Vic biotech job
11 June, 2002 by Tanya HollisFormer head of business development at the Walter and Eliza Hall Institute Dr Amanda Caples has been appointed Victorian Biotechnology Director.
Jobs lost as GroPep facility shuts
11 June, 2002 by Tanya HollisMore than 30 staff at the former Biotech Australia (BA) will lose their jobs in the operational restructure planned by Adelaide growth factor company GroPep.
NSW govt awards aim to reverse the 'brain-drain'
07 June, 2002 by Melissa TrudingerGarvan Institute neurobiologist Dr Bryce Vissel is one of the first recipients of the NSW government's inaugural BioFirst Awards.
Bio 2002 exodus begins
06 June, 2002 by Pete YoungAn exodus of Australian bioscience professionals heading for Toronto and the start of the Bio 2002 conference and exhibition has begun.
Nextec BioSciences and council combine to foster biotech
06 June, 2002 by Tanya HollisInvestment banking group Nextec BioSciences has joined forces with the Melbourne City Council to establish an entrepreneurial incubator for biobusinesses.
BioStart kicks off with Mimetica
06 June, 2002 by Pete YoungThe first investment in a young biotech company has been made by the $6 million BioStart pre-seed fund set up a year ago by the Queensland government.
Rights issue to fund Analytica's new biotech strategy
06 June, 2002 by Pete YoungA $1.3 million rights issue by Analytica Ltd will test investor attitudes toward young biotechs who ask shareholders for a second chance after crashing on the first attempt.
Public gets a say on research focus
05 June, 2002 by Iain ScottThe Commonwealth government is hosting nationwide forums to help it set research priorities.
